GSK shot likely to cost $5/dose, won't stamp out malaria
* Pilot tests in children expected to take 3-5 years
* Experts don't recommend use of vaccine in young babies (Adds detail on cost; comment from GSK, MSF, outside expert)
By Tom Miles and Ben Hirschler
GENEVA/LONDON, Oct 23 (Reuters) - The world's first malaria vaccine is promising but should be used on a pilot basis before any wide-scale use, given its limited efficacy, World Health Organization (WHO) experts said on Friday.
GSK shot likely to cost $5/dose, won't stamp out malaria * Pilot...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $147.0M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.0¢ | $95.42K | 662.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 168013 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 1440985 | 13 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ALA (ASX) Chart |